ImmunoScape
Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Trust80Data Trust: 80/100. Top 25%. Measured by StartupHub.ai. Median 61.Developing novel immunotherapies and diagnostics for cancer.
About
ImmunoScape is a biotechnology company focused on developing novel immunotherapies and diagnostics for cancer. They leverage their proprietary platform to identify and target key immune pathways involved in cancer progression and treatment response. The company is actively pursuing clinical trials to validate their therapeutic candidates.
Listed competitors
Also in this space
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Biotech
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Drug Discovery
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Biotech
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Biotech
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Biotech
Key facts
- Website
- immunoscape.com
- Headquarters
- Singapore, Singapore
- Founded
- 2017
- Total funding
- $47M (Series B2)
- Business model
- B2B
Funding rounds
Tech stack
Detected on immunoscape.com, last scanned 15 Oct 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- Analytics
- Google Tag Manager
- SEO
- Rank Math
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Google Workspace
ImmunoScape scores 29. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
5 reviews from Reddit gathered in one place
Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.
Cue Biopharma announced a strategic collaboration with ImmunoScape that includes $15 million in upfront payments, a figure representing 30% of the company's market capitalization.
Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors.
Cue Biopharma has secured a major strategic collaboration providing a cash infusion equivalent to 25% of its market capitalization, plus a substantial 40% equity stake in its partner, ImmunoScape.
ImmunoScape's Machine Learning Breakthrough: Revolutionizing T-Cell Immunotherapies.
Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.
Frequently asked
Is ImmunoScape trustworthy and reputable?
StartupHub's Data Trust & Reputation score for ImmunoScape is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has ImmunoScape raised?
ImmunoScape has raised a total of $47M in funding. The most recent round on record is Series B2.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for ImmunoScape
